Montelukast Prescribing at REGENT SQUARE GROUP PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,475
Total Quantity
37.8K
NHS Cost
£1.9K
vs National Avg
+115.4%
REGENT SQUARE GROUP PRACTICE prescribed 1,475 items of Montelukast over the last 12 months at a cost of £1,880 to the NHS. This is 115.4% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
127
Jun 2026
103
Jun 2026
140
Jun 2026
117
Jun 2026
126
Jun 2026
129
Jun 2026
120
Jun 2026
135
Jun 2026
118
Jun 2026
114
Jun 2026
132
Jun 2026
114
Prescribing Details
| Total Items | 1,475 |
|---|---|
| Total Quantity | 37,835 |
| Total NHS Cost | £1,880 |
| Presentations | 4 different forms |
| vs National Average | +115.4% |
Montelukast Prescribing Comparison
| This practice | 1,475 items |
|---|---|
| National average per practice | 685 items |
| Difference | +115.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.